Back to search

Netherlands· NL-21bf9304ddac

Soluprick SQ Timotheegraspollen 10.000 BU/ml, oplossing voor huidpriktest

A tests for allergic diseases product containing waterig extract van timotheegraspollen, registered in Netherlands by ALK Abello B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC V04CL

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedSoluprick SQ Timotheegraspollen 10.00…ATCV04CLREGISTER NO.NL-21bf9304ddacPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Waterig extract van timotheegraspollen is registered in 11 of 19 countries.

Countries holding a registration under ATC V04CL (tests for allergic diseases), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose

Waterig extract van timotheegraspollen · ATC V04CL

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
WATERIG EXTRACT VAN TIMOTHEEGRASPOLLEN
Manufacturer
ALK Abello B.V.
Country
Netherlands (NL)
ATC code
V04CL
ATC class
Tests for allergic diseases
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    127671

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Waterig extract van timotheegraspollen in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All waterig extract van timotheegraspollen products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Austria · Oraltek, Prick Test Lieschgras Leti
  • Germany · Prick Test Lieschgras Leti, Provokationstest Lieschgras Leti

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7f2f9061-c81d-4e96-8c9a-31ffb93b504a
GET /v1/drugs/7f2f9061-c81d-4e96-8c9a-31ffb93b504a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor huidpriktest",
  "route": "Intradermaal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h127671_smpc.pdf",
  "strength": null,
  "atc_label": "Tests For Allergic Diseases",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg127671",
  "excipients": [
    "DINATRIUMWATERSTOFFOSFAAT 2-WATER (E 339)",
    "FENOL",
    "GLYCEROL (E 422)",
    "NATRIUMCHLORIDE",
    "NATRIUMDIWATERSTOFFOSFAAT 2-WATER (E 339)",
    "NATRIUMHYDROXIDE (E 524)",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "WATERIG EXTRACT VAN TIMOTHEEGRASPOLLEN"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h127671.pdf",
  "authorised_at": "2021/11/17",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "127671",
  "additional_monitoring": "N"
}

See everything about waterig extract van timotheegraspollen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.